Historical record - last NADAC effective date: 5/22/2024
Product Information
SODIUM CHLORIDE 0.9% VIAL is a generic product labeled by Fresenius Kabi USA, LLC, priced at $0.0584 per ML under NDC 63323018620. Its NADAC has been published 109 times since Nov 19, 2014.
FDA first approved this application on Jan 10, 1985. Its Orange Book therapeutic-equivalence code is AP.
Strength
9 mg/mL
Manufacturer
Fresenius Kabi USA, LLCNDC
63323018620
Classification
Generic
Dosage Form
INJECTION
Route
INTRAVENOUS
Effective Date
5/22/2024
Active Ingredients
SODIUM CHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA088912FDA Approved
1/10/1985
TE Code
AP
On Market Since
8/10/2000
Pharmacological Classes
Price Statistics
The NADAC for SODIUM CHLORIDE 0.9% VIAL has been published 109 times since Nov 19, 2014, and over the history we have for it it has risen 12.5%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0584 per ML |
|---|---|
| All-time high | $0.0584 (May 14, 2025) |
| All-time low | $0.0519 (Nov 19, 2014) |
| Median price | $0.0519 |
| Average price | $0.0550 |
| Largest weekly change | +12.5% (May 22, 2024) |
| Weeks tracked | 109 |
| Tracking since | Nov 19, 2014 |
1W
N/A
1M
N/A
3M
N/A
6M
N/A
1Y
N/A
3Y
+12.5%
5Y
+12.5%
All
+12.5%
Last surveyed May 14, 2025 — this NDC no longer appears in the current weekly NADAC file.
Generic Alternatives
The matcher finds 2 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 53% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Fresenius Kabi USA, LLC manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
SODIUM CHLORIDE market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Osmotic Laxative class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of SODIUM CHLORIDE 0.9% VIAL?
The current National Average Drug Acquisition Cost (NADAC) for SODIUM CHLORIDE 0.9% VIAL, manufactured by Fresenius Kabi USA, LLC, is $0.0584 per ML (NDC 63323018620), effective May 14, 2025.
How has the price of SODIUM CHLORIDE 0.9% VIAL changed over time?
Over the history we have for it, the NADAC for SODIUM CHLORIDE 0.9% VIAL has risen 12.5%. It has been tracked across 109 weekly CMS publications since Nov 19, 2014.
What are the highest and lowest recorded NADAC prices for SODIUM CHLORIDE 0.9% VIAL?
Since Nov 19, 2014, the NADAC for SODIUM CHLORIDE 0.9% VIAL has ranged from a low of $0.0519 (Nov 19, 2014) to a high of $0.0584 (May 14, 2025), with a median of $0.0519 per ML.
Are there cheaper alternatives to SODIUM CHLORIDE 0.9% VIAL?
Yes. 2 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, BACTERIOSTATIC SALINE VIAL, is $0.0273 per ML — about 53% below SODIUM CHLORIDE 0.9% VIAL.
Who manufactures SODIUM CHLORIDE 0.9% VIAL?
SODIUM CHLORIDE 0.9% VIAL (NDC 63323018620) is labeled by Fresenius Kabi USA, LLC, and CMS classifies it as a generic product.